STRM vs. SST, MAQC, GEG, IDN, AIXI, PODC, WCT, AOGO, LGCL, and BMR
Should you be buying Streamline Health Solutions stock or one of its competitors? The main competitors of Streamline Health Solutions include System1 (SST), Maquia Capital Acquisition (MAQC), Great Elm Group (GEG), Intellicheck (IDN), Xiao-I (AIXI), PodcastOne (PODC), Wellchange (WCT), Arogo Capital Acquisition (AOGO), Lucas GC (LGCL), and Beamr Imaging (BMR). These companies are all part of the "computer software" industry.
Streamline Health Solutions vs.
Streamline Health Solutions (NASDAQ:STRM) and System1 (NYSE:SST) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, community ranking, institutional ownership, earnings, valuation and profitability.
In the previous week, Streamline Health Solutions had 1 more articles in the media than System1. MarketBeat recorded 1 mentions for Streamline Health Solutions and 0 mentions for System1. Streamline Health Solutions' average media sentiment score of 0.44 beat System1's score of 0.00 indicating that Streamline Health Solutions is being referred to more favorably in the media.
Streamline Health Solutions has a beta of 1.55, meaning that its stock price is 55% more volatile than the S&P 500. Comparatively, System1 has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500.
System1 has a net margin of -24.18% compared to Streamline Health Solutions' net margin of -50.51%. Streamline Health Solutions' return on equity of -56.96% beat System1's return on equity.
Streamline Health Solutions has higher earnings, but lower revenue than System1. Streamline Health Solutions is trading at a lower price-to-earnings ratio than System1, indicating that it is currently the more affordable of the two stocks.
31.7% of Streamline Health Solutions shares are owned by institutional investors. Comparatively, 87.5% of System1 shares are owned by institutional investors. 30.6% of Streamline Health Solutions shares are owned by insiders. Comparatively, 14.1% of System1 shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
System1 has a consensus target price of $2.00, suggesting a potential upside of 197.62%. Given System1's higher possible upside, analysts plainly believe System1 is more favorable than Streamline Health Solutions.
Streamline Health Solutions received 223 more outperform votes than System1 when rated by MarketBeat users. Likewise, 47.67% of users gave Streamline Health Solutions an outperform vote while only 16.67% of users gave System1 an outperform vote.
Summary
Streamline Health Solutions beats System1 on 11 of the 17 factors compared between the two stocks.
Get Streamline Health Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for STRM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Streamline Health Solutions Competitors List
Related Companies and Tools
This page (NASDAQ:STRM) was last updated on 2/22/2025 by MarketBeat.com Staff